Page last updated: 2024-11-02

pifithrin and Amyotrophic Lateral Sclerosis

pifithrin has been researched along with Amyotrophic Lateral Sclerosis in 2 studies

pifithrin: a tetrahydrobenzothiazol; inhibitor of P53 that protects mice from the side effects of cancer therapy; structure in first source

Amyotrophic Lateral Sclerosis: A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94)

Research Excerpts

ExcerptRelevanceReference
"Dexpramipexole is a BTZ structural analog of riluzole and was a great hope for the treatment of ALS."6.66From Riluzole to Dexpramipexole via Substituted-Benzothiazole Derivatives for Amyotrophic Lateral Sclerosis Disease Treatment: Case Studies. ( Desaphy, JF; Lentini, G; Majoral, JP; Mignani, S, 2020)
"Dexpramipexole is a BTZ structural analog of riluzole and was a great hope for the treatment of ALS."2.66From Riluzole to Dexpramipexole via Substituted-Benzothiazole Derivatives for Amyotrophic Lateral Sclerosis Disease Treatment: Case Studies. ( Desaphy, JF; Lentini, G; Majoral, JP; Mignani, S, 2020)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Mignani, S1
Majoral, JP1
Desaphy, JF1
Lentini, G1
Eve, DJ1
Dennis, JS1
Citron, BA1

Reviews

1 review available for pifithrin and Amyotrophic Lateral Sclerosis

ArticleYear
From Riluzole to Dexpramipexole via Substituted-Benzothiazole Derivatives for Amyotrophic Lateral Sclerosis Disease Treatment: Case Studies.
    Molecules (Basel, Switzerland), 2020, Jul-22, Volume: 25, Issue:15

    Topics: Amyotrophic Lateral Sclerosis; Animals; Benzothiazoles; Clinical Trials as Topic; Drug Approval; Dru

2020

Other Studies

1 other study available for pifithrin and Amyotrophic Lateral Sclerosis

ArticleYear
Transcription factor p53 in degenerating spinal cords.
    Brain research, 2007, May-30, Volume: 1150

    Topics: Age Factors; Amyotrophic Lateral Sclerosis; Animals; Behavior, Animal; Benzothiazoles; Case-Control

2007